A generic alternative indicated for Women's Health and Hormone Therapy. The mechanism targets dopamine receptors to support healthy hormone balance and regulate prolactin levels.
Designed to alleviate hormone imbalances by addressing excessive prolactin production to support reproductive health and mitigate symptoms like irregular cycles and lactation issues.
Mechanism of Action
Cabergoline mimics the action of dopamine in the pituitary gland. It binds to dopamine receptors, which sends a signal to stop the overproduction and release of the hormone prolactin into the bloodstream.
Route of Administration
Oral
Onset Time
2–4 hours for prolactin drop
Duration
7–14 days
Contraindications
Uncontrolled hypertension, History of heart valve disorders, History of fibrotic diseases, Hypersensitivity to ergot alkaloids
Severe Adverse Events
Cardiac valve fibrosis, Pulmonary fibrosis, Severe hypotension, Psychotic episodes, Impulse control disorders, Hallucinations
Information for Cabergoline is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
